Breaking News Instant updates and real-time market news.

2021-01-20 19:59:48 DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 19:59 01/20/21 01/20 19:59 01/20/21 19:59	Denali Therapeutics CFO sells 50K shares of common stock In a regulatory filing, Denali Therapeutics disclosed that its CFO Steve Krognes sold 50K shares of common stock on January 15th in a total transaction size of $3.57M, reducing his stake by about 5%.	08 Feb 29 Jan
DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 11/11/20 JPMorgan Denali Therapeutics price target raised to $65 from $45 at JPMorgan 11/11/20 H.C. Wainwright Denali Therapeutics price target raised to $80 from $65 at H.C. Wainwright 11/10/20 Goldman Sachs Denali Therapeutics price target raised to $81 from $61 at Goldman Sachs 11/06/20 H.C. Wainwright Denali Therapeutics price target raised to $65 from $45 at H.C. Wainwright

2021-01-20 19:59:48

DNLI

Denali Therapeutics

$77.47 / +1.58 (+2.08%)

19:59

01/20/21

01/20

19:59

01/20/21

19:59

Denali Therapeutics CFO sells 50K shares of common stock

In a regulatory filing, Denali Therapeutics disclosed that its CFO Steve Krognes sold 50K shares of common stock on January 15th in a total transaction size of $3.57M, reducing his stake by about 5%.

08
Feb

29
Jan

DNLI Denali Therapeutics

$77.47 / +1.58 (+2.08%)

11/11/20 JPMorgan: Denali Therapeutics price target raised to $65 from $45 at JPMorgan

11/11/20 H.C. Wainwright: Denali Therapeutics price target raised to $80 from $65 at H.C. Wainwright

11/10/20 Goldman Sachs: Denali Therapeutics price target raised to $81 from $61 at Goldman Sachs

11/06/20 H.C. Wainwright: Denali Therapeutics price target raised to $65 from $45 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Recommendations	Swiss Life price target raised to CHF 446 from CHF 424 at Morgan Stanley » 14:39 03/04/21 03/04 14:39 03/04/21 14:39 SZLMY Swiss Life $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SZLMY Swiss Life $0.00 / + (+0.00%) 14:34 Today Berenberg Swiss Life price target lowered to CHF 492.90 from CHF 501.80 at Berenberg 06:30 Today HSBC Swiss Life downgraded to Hold from Buy at HSBC 03/03/21 JPMorgan Swiss Life price target raised to CHF 460 from CHF 440 at JPMorgan 03/03/21 Credit Suisse Swiss Life price target raised to CHF 455 from CHF 365 at Credit Suisse
Recommendations	Persimmon price target raised to 3,000 GBp from 2,950 GBp at Morgan Stanley » 14:38 03/04/21 03/04 14:38 03/04/21 14:38 PSMMY Persimmon $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PSMMY Persimmon $0.00 / + (+0.00%) 13:24 Today JPMorgan Persimmon price target raised to 3,360 GBp from 3,210 GBp at JPMorgan 02/03/21 Barclays Persimmon upgraded to Overweight from Equal Weight at Barclays 02/01/21 Deutsche Bank Persimmon price target raised to 3,283 GBp from 3,173 GBp at Deutsche Bank 01/29/21 Berenberg Persimmon price target raised to 3,180 GBp from 2,720 GBp at Berenberg
Recommendations	Flutter price target raised to 17,700 GBp from 17,400 GBp at Morgan Stanley » 14:38 03/04/21 03/04 14:38 03/04/21 14:38 PDYPY Flutter Entertainment $0.00 / + (+0.00%) Morgan Stanley analyst Ed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/23/21 Texas proposes constitutional amendment to legalize sports wagering 02/19/21 NCAA to allow up to 25% capacity at men's basketball tournament PDYPY Flutter Entertainment $0.00 / + (+0.00%) 13:23 Today JPMorgan Flutter price target raised to 15,038 GBp from 14,790 GBp at JPMorgan 03/03/21 RBC Capital Flutter price target raised to 15,700 GBp from 15,000 GBp at RBC Capital 02/26/21 JPMorgan Flutter price target raised to 14,790 GBp from 11,200 GBp at JPMorgan 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/28/21 FanDuel, Genius Sports to collaborate on marketing initiative, IGB reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test
Recommendations	Elkem ASA price target raised to NOK 30 from NOK 26 at Morgan Stanley » 14:37 03/04/21 03/04 14:37 03/04/21 14:37 ELKEF Elkem ASA $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ELKEF Elkem ASA $0.00 / + (+0.00%) 02/03/21 Nordea Elkem ASA upgraded to Buy from Hold at Nordea 01/27/21 Morgan Stanley Elkem ASA price target raised to NOK 26 from NOK 24 at Morgan Stanley 01/20/21 DNB Markets Elkem ASA downgraded to Hold from Buy at DNB Markets 06/24/20 Citi Elkem ASA downgraded to Sell from Neutral at Citi
Recommendations	Eiffage price target raised to EUR 124 from EUR 121 at Morgan Stanley » 14:37 03/04/21 03/04 14:37 03/04/21 14:37 EFGSY Eiffage $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EFGSY Eiffage $0.00 / + (+0.00%) 03/03/21 RBC Capital Eiffage price target raised to EUR 105 from EUR 100 at RBC Capital 02/25/21 Barclays Eiffage price target raised to EUR 102 from EUR 100 at Barclays 01/14/21 JPMorgan Eiffage price target raised to EUR 92 from EUR 90 at JPMorgan 12/17/20 Morgan Stanley Eiffage price target raised to EUR 117 from EUR 110 at Morgan Stanley

Recommendations	Andritz price target raised to EUR 40 from EUR 38 at Morgan Stanley » 14:36 03/04/21 03/04 14:36 03/04/21 14:36 ADRZY Andritz $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ADRZY Andritz $0.00 / + (+0.00%) 02/11/21 Deutsche Bank Andritz price target raised to EUR 46 from EUR 38 at Deutsche Bank 11/06/20 JPMorgan Andritz price target raised to EUR 42 from EUR 40 at JPMorgan 11/06/20 Morgan Stanley Andritz price target raised to EUR 38 from EUR 36 at Morgan Stanley 11/06/20 Deutsche Bank Andritz price target raised to EUR 38 from EUR 36 at Deutsche Bank
General news	Wall Street turned sharply lower following Fed Chair Powell » 14:35 03/04/21 03/04 14:35 03/04/21 14:35 Wall Street turned… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Amgen deal for Five Prime 'a nice tuck-in,' says Piper Sandler » 14:34 03/04/21 03/04 14:34 03/04/21 14:34 AMGN Amgen $222.71 / -1.1 (-0.49%) , FPRX Five Prime $37.81 / +16.59 (+78.18%) After Amgen (AMGN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash 03/02/21 Amgen announces publication with data from Phase 3 study of BLINCYTO FPRX Five Prime $37.81 / +16.59 (+78.18%) 09:00 Today Five Prime trading resumes 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 14:13 Today Goldman Sachs Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs 03/01/21 Piper Sandler Piper Sandler remains buyer of Amgen following asthma data 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley 02/03/21 Credit Suisse Amgen price target lowered to $265 from $280 at Credit Suisse FPRX Five Prime $37.81 / +16.59 (+78.18%) 14:13 Today Goldman Sachs Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs 10:58 Today Wedbush Five Prime downgraded to Neutral from Outperform at Wedbush 10:29 Today Wells Fargo Five Prime downgraded to Equal Weight from Overweight at Wells Fargo 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 08:34 Today Amgen backs FY21 adjusted EPS view $16.00-$17.00, consensus $16.85 02/02/21 Amgen sees FY21 adjusted EPS $16.00-$17.00, consensus $17.02 02/02/21 Amgen reports Q4 adjusted EPS $3.81, consensus $3.39 02/02/21 Notable companies reporting after market close FPRX Five Prime $37.81 / +16.59 (+78.18%) 11/03/20 Five Prime reports Q3 EPS (74c), consensus (60c) 13 Nov AMGN AMGN Amgen $222.71 / -1.1 (-0.49%) 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 01/28/21 Amgen's sotorasib shrank tumors in 37% of trial patients, STAT reports AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 02/08/21 Fly Insider: Harley-Davidson, Amgen among week's notable insider trades 02/03/21 Fly Intel: Wall Street's top stories for Wednesday FPRX Five Prime $37.81 / +16.59 (+78.18%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 01/15/21 Fly Intel: Pre-market Movers 11/12/20 Fly Intel: Wall Street's top stories for Thursday 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/10/21 Five Prime - FPRX 08/16/21 PDUFA Date for Sotorasib AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 12/29/20 Early notable gainers among liquid option names on December 29th FPRX Five Prime $37.81 / +16.59 (+78.18%) 11/12/20 Unusually active option classes on open November 12th
Recommendations	Swiss Life price target lowered to CHF 492.90 from CHF 501.80 at Berenberg » 14:34 03/04/21 03/04 14:34 03/04/21 14:34 SZLMY Swiss Life $0.00 / + (+0.00%) Berenberg analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SZLMY Swiss Life $0.00 / + (+0.00%) 06:30 Today HSBC Swiss Life downgraded to Hold from Buy at HSBC 03/03/21 JPMorgan Swiss Life price target raised to CHF 460 from CHF 440 at JPMorgan 03/03/21 Credit Suisse Swiss Life price target raised to CHF 455 from CHF 365 at Credit Suisse 01/21/21 JPMorgan Swiss Life price target raised to CHF 440 from CHF 350 at JPMorgan
Recommendations	Shop Apotheke price target raised to EUR 235 from EUR 205 at Berenberg » 14:33 03/04/21 03/04 14:33 03/04/21 14:33 SAEYY Shop Apotheke $0.00 / + (+0.00%) Berenberg analyst Gerhard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SAEYY Shop Apotheke $0.00 / + (+0.00%) 01/21/21 Berenberg Shop Apotheke price target raised to EUR 205 from EUR 170 at Berenberg 01/12/21 Jefferies Shop Apotheke downgraded to Hold from Buy at Jefferies 01/12/21 Barclays Shop Apotheke price target raised to EUR 195 from EUR 190 at Barclays

Recommendations	Renishaw price target raised to 6,600 GBp from 6,200 GBp at Berenberg » 14:32 03/04/21 03/04 14:32 03/04/21 14:32 RNSHF Renishaw $0.00 / + (+0.00%) Berenberg analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RNSHF Renishaw $0.00 / + (+0.00%) 02/05/21 Berenberg Renishaw price target raised to 6,600 GBp from 6,200 GBp at Berenberg 02/05/21 Barclays Renishaw price target raised to 5,185 GBp from 4,350 GBp at Barclays 02/05/21 Morgan Stanley Renishaw price target raised to 5,100 GBp from 4,900 GBp at Morgan Stanley 10/30/20 Barclays Renishaw price target raised to 4,350 GBp from 2,940 GBp at Barclays
Recommendations	LafargeHolcim price target raised to CHF 52 from CHF 51 at Berenberg » 14:31 03/04/21 03/04 14:31 03/04/21 14:31 HCMLY LafargeHolcim $0.00 / + (+0.00%) Berenberg analyst Harry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 02/01/21 Cemex to divest certain assets in France to LafargeHolcim HCMLY LafargeHolcim $0.00 / + (+0.00%) 03/01/21 Credit Suisse LafargeHolcim price target raised to CHF 67 from CHF 64 at Credit Suisse 03/01/21 Morgan Stanley LafargeHolcim price target raised to CHF 64 from CHF 63 at Morgan Stanley 01/27/21 Exane BNP Paribas LafargeHolcim downgraded to Neutral from Outperform at Exane BNP Paribas 01/22/21 JPMorgan LafargeHolcim price target lowered to CHF 57 from CHF 59 at JPMorgan HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	Howden Joinery price target raised to 840 GBp from 830 GBp at Berenberg » 14:31 03/04/21 03/04 14:31 03/04/21 14:31 HWDJF Howden Joinery $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HWDJF Howden Joinery $0.00 / + (+0.00%) 02/26/21 JPMorgan Howden Joinery price target raised to 772 GBp from 679 GBp at JPMorgan 02/26/21 Canaccord Howden Joinery price target raised to 735 GBp from 710 GBp at Canaccord 01/29/21 Berenberg Howden Joinery upgraded to Buy from Hold at Berenberg 01/14/21 Canaccord Howden Joinery price target raised to 710 GBp from 675 GBp at Canaccord
Syndicate	Catalyst Biosciences files $150M mixed securities shelf 14:29 03/04/21 03/04 14:29 03/04/21 14:29 CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 08:07 Today Catalyst Biosciences announces expected near-term milestones 02/03/21 Catalyst Biosciences presents SQ treatement of bleeds data 12/07/20 Catalyst Biosciences presents Crimson 1 Phase 3 study design 12/02/20 Catalyst Biosciences receives FDA fast track designation for MarzAA CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 12:37 Today Piper Sandler Catalyst Biosciences' momentum to build throughout 2021, says Piper Sandler 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Piper Sandler Catalyst Biosciences initiated with an Overweight at Piper Sandler 02/09/21 JonesTrading Catalyst Biosciences assumed with a Buy at JonesTrading CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 08:05 Today Catalyst Biosciences reports Q4 EPS (86c), consensus (86c) 11/05/20 Catalyst Biosciences reports Q3 EPS (73c), consenus (81c) 27 Jan 18 Jun
Recommendations	Gecina price target lowered to EUR 135 from EUR 145 at Berenberg » 14:28 03/04/21 03/04 14:28 03/04/21 14:28 GECFF Gecina $0.00 / + (+0.00%) Berenberg lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GECFF Gecina $0.00 / + (+0.00%) 03/02/21 Barclays Gecina price target lowered to EUR 127 from EUR 132 at Barclays 02/22/21 Morgan Stanley Gecina price target lowered to EUR 120 from EUR 130 at Morgan Stanley 02/19/21 JPMorgan Gecina downgraded to Neutral from Overweight at JPMorgan 02/19/21 Deutsche Bank Gecina price target lowered to EUR 137 from EUR 142 at Deutsche Bank

Recommendations	Croda price target raised to 7,400 GBp from 7,200 GBp at Berenberg » 14:27 03/04/21 03/04 14:27 03/04/21 14:27 COIHY Croda International $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research COIHY Croda International $0.00 / + (+0.00%) 03/03/21 Barclays Croda International price target raised to 6,000 GBp from 5,650 GBp at Barclays 01/25/21 Morgan Stanley Croda price target raised to 6,800 GBp from 6,500 GBp at Morgan Stanley 12/10/20 Berenberg Croda International upgraded to Buy from Hold at Berenberg 12/07/20 Morgan Stanley Croda price target lowered to 6,500 GBp from 6,600 GBp at Morgan Stanley
Options	Teck Resources call volume above normal and directionally bullish » 14:25 03/04/21 03/04 14:25 03/04/21 14:25 TECK Teck Resources $20.44 / -1.17 (-5.41%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options TECK Teck Resources $20.44 / -1.17 (-5.41%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/16/21 Teck Resources doubles water treatment capacity at Elkview operations 01/07/21 Teck Resources, Ktunaxa Nation sign joint management agreement 11/27/20 Teck Resources expands Copper and Health program to Chile TECK Teck Resources $20.44 / -1.17 (-5.41%) 03/01/21 CIBC Teck Resources price target raised to C$32 from C$25 at CIBC 02/19/21 TD Securities Teck Resources price target raised to C$34 from C$30 at TD Securities 02/19/21 RBC Capital Teck Resources price target lowered to C$32 from C$33 at RBC Capital 02/19/21 B. Riley Securities Teck Resources price target raised to C$33 from C$31 at B. Riley Securities TECK Teck Resources $20.44 / -1.17 (-5.41%) 02/18/21 Teck Resources reports Q4 adjusted EPS C$0.46 vs, C$0.40 last year 10/27/20 Teck Resources reports Q3 adj. EPS C$0.24 vs. C$0.69 last year 04/28/21 Teck Resources - TECK TECK Teck Resources $20.44 / -1.17 (-5.41%) 03/03/21 Teck Resources call volume above normal and directionally bullish 02/23/21 Teck Resources put volume heavy and directionally bearish 02/19/21 Teck Resources call volume above normal and directionally bullish 02/12/21 Teck Resources put volume heavy and directionally bearish
Syndicate	Ball Corp. files automatic mixed securities shelf 14:23 03/04/21 03/04 14:23 03/04/21 14:23 BLL Ball Corp. $82.48 / -2.11 (-2.49%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events BLL Ball Corp. $82.48 / -2.11 (-2.49%) 02/10/21 Ball Aerospace selected to integrate, test Sailcraft for NASA 02/09/21 Ball Aerospace to build spacecraft for NASA heliophysics science mission 02/04/21 Ball sees FY21 EPS over growth goal of 10%-15% 01/26/21 Ball Corp.to begin construction on production facility in West of Czech Republic BLL Ball Corp. $82.48 / -2.11 (-2.49%) 01/20/21 Deutsche Bank Ball Corp. price target lowered to $102 from $107 at Deutsche Bank 01/04/21 Baird Baird sees limited upside for Ball Corp, downgrades shares to Neutral 01/04/21 Baird Ball Corp. downgraded to Neutral from Outperform at Baird 11/10/20 Wells Fargo Ball Corp. price target raised to $100 from $80 at Wells Fargo BLL Ball Corp. $82.48 / -2.11 (-2.49%) 02/04/21 Ball reports Q4 EPS 68c, consensus 78c 11/05/20 Ball Corp. reports Q3 comparable EPS 89c, consensus 77c 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open BLL Ball Corp. $82.48 / -2.11 (-2.49%) 12/14/20 Ball Corp. added as short trade best idea at Hedgeye, Bloomberg says 03/03/21 2021 Global Agriculture & Materials Virtual Conference
Technical Analysis	NASDAQ market internals summary » 14:17 03/04/21 03/04 14:17 03/04/21 14:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 14:16 03/04/21 03/04 14:16 03/04/21 14:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary

Options	TJX put volume heavy and directionally bearish » 14:15 03/04/21 03/04 14:15 03/04/21 14:15 TJX TJX $61.39 / -2.28 (-3.58%) Bearish flow noted in TJX… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TJX TJX $61.39 / -2.28 (-3.58%) 02/24/21 TJX not providing detailed FY22 outlook due to continuing uncertainty 02/24/21 TJX sees FY22 pre-tax margins higher than FY21 02/24/21 TJX: Homegoods stores to nearly double to 1,500 over long-term 02/24/21 TJX saw improvement in each month of quarter in open-only comps TJX TJX $61.39 / -2.28 (-3.58%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 Wells Fargo TJX price target raised to $84 from $74 at Wells Fargo 02/25/21 Deutsche Bank TJX price target raised to $76 from $73 at Deutsche Bank 02/25/21 Gordon Haskett TJX downgraded to Hold on mounting margin pressures at Gordon Haskett TJX TJX $61.39 / -2.28 (-3.58%) 02/24/21 TJX reports Q4 EPS 27c, consensus 62c 02/23/21 Notable companies reporting before tomorrow's open 02/23/21 Notable companies reporting before tomorrow's open 11/18/20 TJX reports Q3 EPS 71c, consensus 40c TJX TJX $61.39 / -2.28 (-3.58%) 12/22/20 Overstock eyes potential brick-and-mortar partnerships, AdWeek says TJX TJX $61.39 / -2.28 (-3.58%) 02/24/21 Fly Intel: Pre-market Movers 11/18/20 Fly Intel: Wall Street's top stories for Wednesday 11/18/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Fly Intel: Pre-market Movers TJX TJX $61.39 / -2.28 (-3.58%) 02/22/21 TJX call volume above normal and directionally bullish 02/04/21 TJX call volume above normal and directionally bullish 01/19/21 TJX put volume heavy and directionally bearish 11/18/20 Unusually active option classes on open November 18th
General news	Treasury Action: it was what Fed Chair Powell did not say that shook up the markets » 14:15 03/04/21 03/04 14:15 03/04/21 14:15 Treasury Action: it was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs » 14:13 03/04/21 03/04 14:13 03/04/21 14:13 AMGN Amgen $220.62 / -3.19 (-1.43%) , FPRX Five Prime $37.79 / +16.57 (+78.09%) , BGNE BeiGene $287.67 / -14.24 (-4.72%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AMGN FPRX BGNE AMGN Amgen $220.62 / -3.19 (-1.43%) 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash 03/02/21 Amgen announces publication with data from Phase 3 study of BLINCYTO FPRX Five Prime $37.79 / +16.57 (+78.09%) 09:00 Today Five Prime trading resumes 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash BGNE BeiGene $287.67 / -14.24 (-4.72%) 03/02/21 BeiGene announces Health Canada approval of Brukinsa 02/17/21 BeiGene, Boston Immune enter into pact to develop novel TNFR2 antagonists 02/17/21 BeiGene announces FDA acceptance of Brukinsa sNDA 01/27/21 BeiGene announces positive topline results in ph3 trial of Tislelizumab in ESCC AMGN FPRX BGNE AMGN Amgen $220.62 / -3.19 (-1.43%) 03/01/21 Piper Sandler Piper Sandler remains buyer of Amgen following asthma data 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley 02/03/21 Credit Suisse Amgen price target lowered to $265 from $280 at Credit Suisse 02/03/21 Cantor Fitzgerald Amgen price target raised to $295 from $280 at Cantor Fitzgerald FPRX Five Prime $37.79 / +16.57 (+78.09%) 10:58 Today Wedbush Five Prime downgraded to Neutral from Outperform at Wedbush 10:29 Today Wells Fargo Five Prime downgraded to Equal Weight from Overweight at Wells Fargo 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan 11/11/20 Fly Intel: Top five analyst upgrades BGNE BeiGene $287.67 / -14.24 (-4.72%) 03/01/21 Fly Intel: Top five analyst downgrades 03/01/21 CLSA BeiGene downgraded to Underperform from Outperform at CLSA 02/18/21 Cowen BeiGene price target raised to $429 from $348 at Cowen 01/12/21 Piper Sandler BeiGene price target raised to $190 from $185 at Piper Sandler AMGN FPRX BGNE AMGN Amgen $220.62 / -3.19 (-1.43%) 08:34 Today Amgen backs FY21 adjusted EPS view $16.00-$17.00, consensus $16.85 02/02/21 Amgen sees FY21 adjusted EPS $16.00-$17.00, consensus $17.02 02/02/21 Amgen reports Q4 adjusted EPS $3.81, consensus $3.39 02/02/21 Notable companies reporting after market close FPRX Five Prime $37.79 / +16.57 (+78.09%) 11/03/20 Five Prime reports Q3 EPS (74c), consensus (60c) BGNE BeiGene $287.67 / -14.24 (-4.72%) 02/25/21 BeiGene reports Q4 EPS ($5.20), consensus ($4.81) 11/05/20 BeiGene reports Q3 loss per ADS ($4.81), consensus ($4.12) 02 Dec 13 Nov AMGN AMGN Amgen $220.62 / -3.19 (-1.43%) 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 01/28/21 Amgen's sotorasib shrank tumors in 37% of trial patients, STAT reports AMGN FPRX AMGN Amgen $220.62 / -3.19 (-1.43%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 02/08/21 Fly Insider: Harley-Davidson, Amgen among week's notable insider trades 02/03/21 Fly Intel: Wall Street's top stories for Wednesday FPRX Five Prime $37.79 / +16.57 (+78.09%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 01/15/21 Fly Intel: Pre-market Movers 11/12/20 Fly Intel: Wall Street's top stories for Thursday 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/10/21 Five Prime - FPRX 08/16/21 PDUFA Date for Sotorasib 10/18/21 PDUFA Date for Brukinsa Zanubrutinib (BGB-3111) AMGN FPRX AMGN Amgen $220.62 / -3.19 (-1.43%) 12/29/20 Early notable gainers among liquid option names on December 29th FPRX Five Prime $37.79 / +16.57 (+78.09%) 11/12/20 Unusually active option classes on open November 12th
Recommendations	Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler » 14:11 03/04/21 03/04 14:11 03/04/21 14:11 FULC Fulcrum Therapeutics $12.00 / -2.59 (-17.75%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FULC Fulcrum Therapeutics $12.00 / -2.59 (-17.75%) 07:23 Today Fulcrum Therapeutics CEO Robert Gould to retire, Bryan Stuart to succeed 07:16 Today Fulcrum Therapeutics expects cash to fund requirements into 4Q22 07:16 Today Fulcrum Therapeutics decides to discontinue LOSVID Phase 3 trial 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO FULC Fulcrum Therapeutics $12.00 / -2.59 (-17.75%) 03/01/21 Stifel Fulcrum Therapeutics initiated with a Buy at Stifel 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG FULC Fulcrum Therapeutics $12.00 / -2.59 (-17.75%) 07:15 Today Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 20 Jan 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:00 Today Fulcrum Therapeutics - FULC
Periodicals	Microsoft president Smith to testify at 'Big Tech' antitrust hearing, Axios says » 14:05 03/04/21 03/04 14:05 03/04/21 14:05 MSFT Microsoft $225.59 / -2.03 (-0.89%) , AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) , AAPL Apple $119.56 / -2.51 (-2.06%) , GOOG Alphabet $2,034.80 / +8.81 (+0.43%) , FB Facebook $255.86 / +0.52 (+0.20%) The House Judiciary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 09:22 Today Verb Technology readies for release of Microsoft Outlook integration 09:06 Today Schlumberger, Chevron and Microsoft collaborate on carbon negative bioenergy 03/03/21 Microsoft debuts Group Transcribe, a new Garage app for transcriptions 03/02/21 Microsoft introduces Microsoft Mesh to connect with new depth and dimension AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 07:10 Today United Natural Foods extends distribution pact with Whole Foods Market 03/02/21 Amazon's AWS selected by PGA tour as its official cloud provider 03/02/21 Amazon Web Services launches second region in Japan 03/02/21 Philips appoints Shez Partovi chief innovation and strategy officer AAPL Apple $119.56 / -2.51 (-2.06%) 05:50 Today U.K. launches investigation into Apple following anti-competitive complaints 03/03/21 Best Buy Health to offer Lively health services on Apple Watch 03/02/21 Target to open approx. 100 Ulta Beauty at Target shop-in-shops in 2021 02/25/21 Target announces enhanced Apple shopping experience for customers GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 03/03/21 Google backs plan to remove support for third-party cookies in Chrome 02/25/21 MongoDB expands integration of Atlas database with Google Cloud 02/25/21 Schrodinger expands collaboration with Google Cloud 02/24/21 Sterling National Bank collaborates with Google Pay FB Facebook $255.86 / +0.52 (+0.20%) 03/03/21 Facebook resuming political, electoral, social issue ads tomorrow 03/02/21 Facebook dips as TMT conference presentation continues 03/01/21 Instagram launches Live Rooms feature for Live with up to three people 03/01/21 AudioEye announces Zach Okun as chief product officer MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 03/03/21 Citi Microsoft assumed with a Buy at Citi 02/16/21 Wedbush Microsoft price target raised to $300 from $285 at Wedbush 02/16/21 UBS Workday price target raised to $280 from $235 at UBS 02/08/21 KeyBanc Viva reinforces Microsoft Office/Teams innovation commitment, says KeyBanc AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 03/03/21 Jefferies Google Cloud traction under Kurian 'under-appreciated,' says Jefferies 02/26/21 B. Riley Securities Plug Power recent selloff provides relative discount, says B. Riley 02/17/21 Needham Kornit Digital price target raised to $125 from $76 at Needham 02/17/21 Morgan Stanley Roku price target raised to $275 from $200 at Morgan Stanley AAPL Apple $119.56 / -2.51 (-2.06%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 03/03/21 Jefferies Google Cloud traction under Kurian 'under-appreciated,' says Jefferies 02/17/21 Morgan Stanley Roku price target raised to $275 from $200 at Morgan Stanley 02/12/21 Citi Citi boosts Alphabet target but shares no longer a top pick 02/08/21 Stephens Global Payments merchant business advanced by Google pact, says Stephens FB Facebook $255.86 / +0.52 (+0.20%) 02/26/21 Jefferies Twitter price target raised to $79 from $64 at Jefferies 02/16/21 Loop Capital Facebook price target raised to $370 from $330 at Loop Capital 02/10/21 Tigress Financial Facebook has 'significant upside' at current levels, says Tigress 02/01/21 Truist Alphabet price target raised to $2,100 from $2,000 at Truist MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Amazon.com sees Q1 revenue $100B-$106B , consensus $95.69B 02/02/21 Amazon.com reports Q4 EPS $14.09, consensus $7.23 02/02/21 Notable companies reporting after market close AAPL Apple $119.56 / -2.51 (-2.06%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Alphabet reports Q4 EPS $22.30, consensus $15.90 02/02/21 Notable companies reporting after market close 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago FB Facebook $255.86 / +0.52 (+0.20%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 02/28/21 Microsoft says vaccine tools have 'fallen short,' Bloomberg reports 02/23/21 Google lobbying Senate to press Microsoft on SolarWinds hack, Politico reports 02/22/21 Google hit with class-action suit over Stadia 4K promises, PCGamer says 02/21/21 Gates says social media bans not answer to divisiveness, Bloomberg reports AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 12:14 Today Amazon's Halo fitness tracker to receive Alexa integration, Verge reports 06:13 Today Parler accuses Amazon of anticompetitive conduct in new lawsuit, WSJ reports 03/03/21 Amazon in talks to carry 'many' exclusive NFL games on Prime Video, WSJ says 03/02/21 Amazon to open first Amazon Go store in the U.K. this week, The Mirror reports AAPL Apple $119.56 / -2.51 (-2.06%) 13:12 Today Apple could face EU antitrust charges following Spotify complaint, Reuters says 03/03/21 Apple and Alphabet may hindered by new Arizona app payment rules. Verge says 03/03/21 Apple could launch foldable iPhone as soon as 2023, Business Insider reports 03/02/21 New Apple Card users get 6% Daily Cash on Apple purchases, 9to5Mac says GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 03/03/21 Apple and Alphabet may hindered by new Arizona app payment rules. Verge says 03/03/21 Infosys wins $500M all-digital deal from Google, The Economic Times says 02/28/21 Reliance partners with Google, Facebook for payment network bid, Reuters says 02/26/21 Stadia missed initial sales targets by 'hundreds of thousands,' Bloomberg says FB Facebook $255.86 / +0.52 (+0.20%) 03/03/21 Facebook deal for Kustomer facing 'extensive antitrust review,' Information says 02/28/21 Reliance partners with Google, Facebook for payment network bid, Reuters says 02/24/21 Facebook exploring potential media licensing agreements in Canada, Reuters says 02/21/21 White House working with Facebook, Twitter to tackle anti-vaxxers, Reuters says MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 11:16 Today Fly Intel: What to watch in Slack earnings report 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/24/21 Fly Intel: What to watch in Nvidia earnings report AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 03/01/21 Fly Intel: What to watch in Target's earnings report AAPL Apple $119.56 / -2.51 (-2.06%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/24/21 #SocialStocks: Snap shares advance following first investor day 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/23/21 Game On: An exclusive talk with Skeleton Crew's Olsson and Murakami FB Facebook $255.86 / +0.52 (+0.20%) 03/03/21 #SocialStocks: Facebook resumes political ads, Twitter announces long-term goals 02/28/21 Opening Day: Coinbase files to go public 02/24/21 #SocialStocks: Snap shares advance following first investor day 02/23/21 Fly Intel: Wall Street's top stories at midday 03/17/21 Technology 03/17/21 Technology 03/10/21 2nd Annual Enterprise Comms Virtual Summit 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference MSFT AMZN AAPL GOOG FB MSFT Microsoft $225.59 / -2.03 (-0.89%) 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th AMZN Amazon.com $2,969.00 / -39.2 (-1.30%) 02/02/21 Amazon options imply 7.6% move in share price post-earnings 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th AAPL Apple $119.56 / -2.51 (-2.06%) 08:55 Today Notable open interest changes for March 4th 03/03/21 Notable open interest changes for March 3rd 03/02/21 Notable open interest changes for March 2nd 03/02/21 Apple call buyer realizes 91% same-day gains GOOG Alphabet $2,034.80 / +8.81 (+0.43%) 02/02/21 Alphabet options imply 6.6% move in share price post-earnings 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th FB Facebook $255.86 / +0.52 (+0.20%) 02/16/21 Facebook call volume above normal and directionally bullish 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains

Events

Earnings calls, analyst events, roadshows and more

MTSI
Today at 15:00

MACOM Technology Solutions Holdings, Inc. Firm Sponsored Meetings

the Holiday Inn Express, 8 Independence Drive, Chelmsford, MA
Today at 16:30

Fed Balance Sheet Total Assets W/W: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Level: Week 3/3/21 Government Event
SENS
Today at 16:30

Senseonics - SENS Conference Calls
MANU
Today at 16:30

Manchester United - MANU Conference Calls
QUMU
Today at 16:30

Qumu - QUMU Conference Calls
ACOR
Today at 16:30

Acorda Therapeutics - ACOR Conference Calls
ATEC
Today at 16:30

Alphatec - ATEC Conference Calls
CLPT
Today at 16:30

ClearPoint Neuro - CLPT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

Denali Therapeutics CFO sells 50K shares of common stock

TODAY'S FREE FLY STORIES

Get Full Fly Access